EU Body Warns Against Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts)'s Velcade Use in Some Patients

March 21, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON, March 20 (Reuters) - The European Medicines Agency has recommended that Millennium Pharmaceuticals Inc's (MLNM.O: Quote, Profile, Research) cancer drug Velcade should not be used in patients with certain severe pulmonary or heart problems.

Twitter
LinkedIn
Facebook
Email
Print

Europe